Expression of Key Steroidogenic Enzymes in Human Placenta and Associated Adverse Pregnancy Outcomes
- PMID: 40416852
- PMCID: PMC12096406
- DOI: 10.1097/FM9.0000000000000167
Expression of Key Steroidogenic Enzymes in Human Placenta and Associated Adverse Pregnancy Outcomes
Abstract
Steroid hormones, including progestagens, estrogens, androgens, corticosteroids, and their precursor cholesterol, perform essential functions in the successful establishment and maintenance of pregnancy and normal fetal development. As the core endocrine organ at the prenatal stage, the human placenta is involved in the biosynthesis, metabolism, and delivery of steroid hormones. Steroidogenic pathways are tightly regulated by placenta-intrinsic cytochrome P450 and hydroxysteroid dehydrogenase. However, the relationship between placental steroidogenic enzyme expression and adverse pregnancy outcomes is controversial. In this review, we summarize the possible upstream regulatory mechanisms of placental steroidogenic enzymes in physiologic and pathophysiologic states. We also describe the human placental barrier model and examine the potential of single-cell sequencing for evaluating the primary functions and cellular origin of steroidogenic enzymes. Finally, we examine the existing evidence for the association between placental steroidogenic enzyme dysregulation and adverse pregnancy outcomes.
Keywords: Cytochrome P450; Hydroxysteroid dehydrogenase; Maternal-fetal outcomes; Placenta; Steroidogenic enzymes.
Copyright © 2022 The Chinese Medical Association, published by Wolters Kluwer Health, Inc.
Conflict of interest statement
None.
References
LinkOut - more resources
Full Text Sources
Research Materials